These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 17396618

  • 1. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T, Tachikawa S, Kondo R, Miyazaki J, Shiga M, Hirose M, Kobayashi K, Hayashi N, Ohira D, Nasu T, Otake Y, Hata H.
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [Abstract] [Full Text] [Related]

  • 2. Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma.
    Horiguchi T, Tachikawa S, Kondo R, Shiga M, Hirose M, Ito T.
    Arzneimittelforschung; 2003; 53(10):714-21. PubMed ID: 14650364
    [Abstract] [Full Text] [Related]

  • 3. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 4. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
    Tamaoki J, Isono K, Taira M, Tagaya E, Nakata J, Kawatani K, Nagai A.
    Allergy Asthma Proc; 2008 Mar; 29(2):189-96. PubMed ID: 18430318
    [Abstract] [Full Text] [Related]

  • 5. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
    Tamaoki J, Yokohori N, Tagaya E, Kirishi S, Miyamoto Y, Ochiai K, Kondo M, Nagai A.
    Allergy Asthma Proc; 2010 Mar; 31(5):78-84. PubMed ID: 20929598
    [Abstract] [Full Text] [Related]

  • 6. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
    Pavord I, Woodcock A, Parker D, Rice L, SOLTA study group.
    Respir Res; 2007 Sep 27; 8(1):67. PubMed ID: 17897478
    [Abstract] [Full Text] [Related]

  • 7. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar 27; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 8. Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.
    Yoo SH, Park SH, Song JS, Kang KH, Park CS, Yoo JH, Choi BW, Hahn MH, Representing Korea Pranlukast Study Group.
    Respirology; 2001 Mar 27; 6(1):15-21. PubMed ID: 11264758
    [Abstract] [Full Text] [Related]

  • 9. Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma.
    Ishioka S, Hozawa S, Haruta Y, Hiyama K, Maeda A, Yamakido M.
    Hiroshima J Med Sci; 1999 Dec 27; 48(4):105-10. PubMed ID: 10804983
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
    Tomari S, Shimoda T, Kawano T, Mitsuta K, Obase Y, Fukushima C, Matsuse H, Kohno S.
    Ann Allergy Asthma Immunol; 2001 Aug 27; 87(2):156-61. PubMed ID: 11527250
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
    Horiguchi T, Hayashi N, Ohira D, Torigoe H, Ito T, Hirose M, Sasaki Y, Shiga M, Miyazaki J, Kondo R, Tachikawa S.
    J Asthma; 2006 Sep 27; 43(7):509-12. PubMed ID: 16939990
    [Abstract] [Full Text] [Related]

  • 15. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma.
    Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC.
    Thorax; 2002 Mar 27; 57(3):226-30. PubMed ID: 11867826
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 19. Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations.
    Belda J, Margarit G, Martínez C, Bellido-Casado J, Casan P, Torrejón M, Brufal M, Rodríguez-Jerez F, Sanchis J.
    Eur Respir J; 2007 Dec 29; 30(6):1143-9. PubMed ID: 17690122
    [Abstract] [Full Text] [Related]

  • 20. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
    Horiguchi T, Kondo R, Miyazaki J, Shiga M, Sugiyama M, Hirose M, Tachikawa S.
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct 29; 41(10):696-703. PubMed ID: 14584388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.